Insider buying last 90 days
No open-market insider purchases were filed for AFYA in the last 90 days.
From Form 4 filings, dated to when each was filed.
Oct 12 close
Afya shares have drawn attention this week from several value-focused commentaries, including a comparison against Universal Technical Institute and a piece questioning whether the stock remains attractive for value investors, alongside a note that shares climbed 4.5% to $13.91 on 6 October. A Form 4 filing on 11 October coincided with a reported 4.24% increase in the stock but carried little additional detail. Together, the coverage centers on valuation questions rather than new operational or regulatory developments.
Afya closed at $14.85, up 0.7%, sitting between its 50-day average of $13.77 and 200-day average of $14.31, a mixed trend signal. The GekkoIndex reads 46.2, placing the stock in the Neutral zone, though the index has fallen 14.2 points over the past five sessions. The price stands 40.8% below the Gekko Fair Value of $25.07, a gap that remains wide relative to recent trading levels.
Afya's next earnings report is scheduled for 12 November 2026 after the close, 30 days out and beyond a typical 20-trading-day holding window. Over the prior eight quarters, the company beat estimates 7 times, with an average absolute reaction of 4% to results. Seasonality over the next 20 trading days has averaged 3.7% across 5 years, with gains in 3 of them. No insider, Congress or unusual options activity appears in the current windows, leaving analyst sentiment, where both covering firms rate the stock a buy with a consensus target of $17.61, as the more visible signal worth noting.
Written by AI from the Oct 12, 2026 close and checked automatically against the figures on this page.
Afya scores 3 supportive, 2 mixed and 0 headwinds across the 5 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
3 supportive2 mixed0 headwinds
Averages disagree
Close $14.85 sits between the 50-day ($13.77) and 200-day ($14.31) averages, or the averages disagree.
See the chart46.2, Neutral
Reading 46.2 is in the Neutral zone.
See the GekkoIndex40.8% below
Price is 40.8% below Gekko Fair Value (more than 5% below).
See fair valueNo data
No insider, Congress or unusual options activity in the window.
See smart moneyReports in 31 days
Next report Nov 12, 2026, 31 days away — outside a typical 20-trading-day hold.
See earnings+3.7% on average
From this point in the calendar, the next 20 trading days averaged +3.7% over 5 years, rising in 3 of them.
See seasonalityA description of current data, not a recommendation. How this page works
Afya closed at $14.85 on Oct 12, 2026, −0.8% over the past year, inside a 52-week range of $11.62 to $16.16.
Use the left and right arrow keys to read daily values.
Put AFYA on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Afya works through a group of subsidiaries to provide medical education across Brazil. Its programs cover medical schools, residency preparation, graduate studies, and continuing education for professionals at different stages of their careers, offered both through its own network and to outside institutions. It is also known for a subscription-based digital platform, reached by app or website, that gives clinicians and students tools like medical calculators, reference material, prescription guidance, scoring systems, and lab test information to support decisions at the point of care.
Its academic offerings reach beyond medicine into fields such as dentistry, nursing, psychology, pharmacy, physiotherapy, nutrition, and biomedicine, and extend further into business, accounting, law, and engineering degrees. Afya rounds out this structure with postgraduate medical programs, printed and digital course materials, an online learning platform, and practical training components, built around a network of undergraduate and graduate medical campuses with a set number of approved and operating seats for students.
Afya was founded in 1999 and is based in Nova Lima, Brazil. Its shares are listed on the NASDAQ under the ticker AFYA.
Afya’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 46.2, in the Neutral zone, down 14.2 points over five sessions.
Down 14.2 points over five sessions, from the Accumulation zone.
Reading for Oct 12, 2026
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 48 | +1.5% | +5.2% | ||
| Accumulation | 270 | +0.5% | +0.6% | ||
| Neutral (current zone) | 353 | −0.8% | −2.7% | ||
| Distribution | 7 | Too few readings yet | |||
| Selling | 4 | Too few readings yet | |||
Average AFYA share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Neutral readings averaged +1.1% over 20 days. Past behaviour doesn’t guarantee future results.
Neutral zone: No clear directional signal. About the five zones →
Afya trades 40.8% below Gekko Fair Value of $25.07, so the shares are undervalued on Gekko’s estimate.
Gekko’s own estimate of what Afya shares are worth, recalculated every trading day.
$25.07
Gekko Fair Value, Oct 10, 2026
40.8% Undervalued
At the end of Aug 2026 the price was 7.9% below the estimate.
No open-market insider purchases were filed for Afya, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
No open-market insider purchases were filed for AFYA in the last 90 days.
From Form 4 filings, dated to when each was filed.
No trades in AFYA were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Afya reports on Nov 12, 2026, after the close (31 days away), and beat the EPS estimate in 7 of its last 8 reports.
Nov 12, 2026
Expected after the close, 31 days away
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Mar 27, 2026 | $2.25 est $1.89 | — | −0.1% |
| Nov 12, 2025 | $2.08 est $1.76 | $174.0M est $174.5M | +1.5% |
| Aug 14, 2025 | $2.27 est $1.98 | $169.3M est $173.0M | +0.9% |
| May 8, 2025 | $2.76 est $2.55 | $160.3M est $165.5M | +0.5% |
| Mar 13, 2025 | $2.10 est $1.61 | $136.9M est $160.5M | +11.6% |
| Nov 13, 2024 | $1.79 est $1.84 | $154.0M est $146.3M | −7.8% |
| Aug 14, 2024 | $2.29 est $1.95 | $145.0M est $26.93M | +7.3% |
| May 9, 2024 | $2.74 est $2.35 | $158.8M est $29.51M | −1.9% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Analysts’ average 12-month price target for Afya is $17.61, +18.6% from the last close, from 2 firms rating the stock in the last 90 days.
Each firm’s latest rating in the last 90 days: 2 firms.
| Date | Firm | Target | vs price |
|---|---|---|---|
| Oct 7 | J.P. Morgan | $19 | +27.9% |
| Sep 24 | Bradesco | $17 | +14.5% |
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Over the next 20 trading days from Oct 10, Afya averaged +3.7% across the last 5 years, rising in 3 of them.
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | +0.7% | 4 of 5 |
| Next 10 trading days | −2.4% | 3 of 5 |
| Next 15 trading days | +0.4% | 3 of 5 |
| Next 20 trading days | +3.7% | 3 of 5 |
| Next 30 trading days | +2.7% | 4 of 5 |
For scale, AFYA’s typical 20-trading-day move in either direction is about 6.6%.
Afya’s market cap is $1.34B, with a P/E ratio of 8.6 and revenue of $3.83B over the last twelve months.
4 headlines about Afya from the past week, newest first, each linking to the publisher.
Afya’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| BKNGBooking | Accumulation | 28.5% below |
| EXPEExpedia | Neutral | 2.6% below |
| SCIService Corporation International | Accumulation | 2.1% above |
| LTHLife Time | Accumulation | 15.7% below |
| ANDGAndersen | Neutral | 8.0% below |
| HRBH&R Block | Neutral | 38.0% below |
A peer links to its own page where one exists.
Afya’s market cap is $1.34B at the Oct 12, 2026 close of $14.85, with 49.90M shares outstanding. The shares trade on a P/E ratio of 8.6.
The consensus analyst 12-month price target for Afya is $17.61, +18.6% from the last close. Of the 2 firms that rated the stock in the last 90 days, 2 rate it a buy, 0 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.
On Gekko’s estimate Afya is undervalued: the Oct 12, 2026 close of $14.85 is 40.8% below Gekko Fair Value of $25.07. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
Afya is expected to report on Nov 12, 2026, after the market closes (31 days away). Analysts expect earnings of $0.38 per share on revenue of $194.4M. Afya beat the earnings estimate in 7 of its last 8 reports, moving 4% on average across the report.
Afya’s 52-week high is $16.16 and its 52-week low is $11.62; it closed at $14.85 on Oct 12, 2026, −0.8% over the past year. Over the last five years the shares peaked at $22.48 on Jan 19, 2024.
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 3 of the 5 items with data read as supportive (fair value, earnings risk and seasonality), 2 as mixed (trend and gekkoindex). The checklist is a description of current data, not a recommendation.
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,408 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.Type a ticker or company name. Press Esc to close.